Last update 02 Jun 2025
Shanghai Universal Biotech Co., Ltd.

Shanghai Universal Biotech Co., Ltd.

Public Company|2004|Shanghai Shi, China| SHE: 301166|
mobile.univ-bio.com

Overview

Tags

Other Diseases
Polyclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms2
Nervous System Diseases1
Top 5 Drug TypeCount
Monoclonal antibody4
Polyclonal antibody1
Top 5 TargetCount
TAU(Microtubule-associated protein tau)2
ROR1(Inactive tyrosine-protein kinase transmembrane receptor ROR1)1
FACL4(acyl-CoA synthetase long chain family member 4)1
LCN2(lipocalin 2)1

Related

5
Drugs associated with Shanghai Universal Biotech Co., Ltd.
CN117720654
Patent Mining
Target
LCN2
Mechanism-
Active Org.
Hangzhou Star Biotechnology Co., Ltd.
Originator Org.
Hangzhou Star Biotechnology Co., Ltd.
Active Indication
Male Urogenital Diseases
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
CN115894659
Patent Mining
Target
TAU
Mechanism-
Active Org.
Shanghai Universal Biotech Co., Ltd.Shanghai Universal Biotech Co., Ltd.
Originator Org.
Hangzhou Star Biotechnology Co., Ltd. [+1]
Active Indication
Cognition Disorders
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
CN118406143
Patent Mining
Target
TAU
Mechanism-
Active Org.
Hangzhou Star Biotechnology Co., Ltd.
Originator Org.
Hangzhou Star Biotechnology Co., Ltd.
Active Indication
Dementia
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Shanghai Universal Biotech Co., Ltd.
NCT04408261
/ Unknown statusPhase 2IIT
Buqitongluo Granule for Qi Deficiency and Blood Stasis Syndrome: A Multicenter, Randomized, Double-blind, Placebo-Controlled Trial
100 Clinical Results associated with Shanghai Universal Biotech Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Shanghai Universal Biotech Co., Ltd.
Login to view more data
100 Deals associated with Shanghai Universal Biotech Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai Universal Biotech Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 12 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
5
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
CN118580358
 ( ROR1 )Patent Mining		Neoplasms
More
Discovery
CN115894659
 ( TAU )Patent Mining		Cognition Disorders
More
Discovery
CN118406143
 ( TAU )Patent Mining		Dementia
More
Discovery
CN117866101
 ( FACL4 )Patent Mining		Neoplasms
More
Discovery
CN117720654
 ( LCN2 )Patent Mining		Male Urogenital Diseases
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free